secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2023-10-25T23:59:59+00:00
Accession:  0001437749-23-028904
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key Q3 revenue up 33% to $1.8M, net loss per share narrows to ($0.08) from ($0.29)
--------------------------------------------------------------------------------

- Revenue $1.8M (+33% YoY); gross profit $1.4M (+43%); gross margin 77% vs 71%.
- Operating loss improved to ~$750K from $2.4M; net loss per share ($0.08) vs ($0.29) in Q3'22.
- Nine-month revenue $6.8M (+30%); net loss reduced to $2.5M from $5.1M in year-ago period.
- ARR ~$7M; secured additional order from international defense ministry customer for expanded rollout.
- Cash and equivalents $0.3M; seeking expense reductions including HQ relocation to reach breakeven.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774923028904/0001437749-23-028904-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774923028904/bkyi20231024_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-028904

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer